TP53 and non-small cell lung carcinoma: The average GSH/GSSG levels were ∼50% lower in Onc-p53 NSCLC cell lines (n = 41) compared with the loss-of-function p53 cell lines (n = 11; P < 0.01; Fig. 2A).